As will be discussed below, the combination of uPA and PAI-1 has been shown to be useful as biomarkers of worse prognosis, however one study found that PAI-1 negative, highly uPA-expressing gastric adenocarcinomas were associated with increased volume and number of metastases [22]. Here, SERPINE1 is linked to gastric adenocarcinoma.